MYBL1 and epilepsy: Patients with diffuse astrocytoma, MYB- or MYBL1-altered are mostly diagnosed with drug-resistant seizures, previous study suggested that 81% of these patients develop epilepsy in childhood and the median age of seizure onset is 10 years (Wefers et al., 2020).